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Abstract  
AIM: The aim of the study is to evaluate the changes of the kinetic parameters of gait in patients with 
supratentorial unilateral stroke in the chronic period (SUSChP). 
MATERIAL AND METHODS: The study was conducted with 67 patients with SUSChP (56 patients included in 
the experimental group - 32 men and 24 women, with duration of disease 7.8 ± 2.0 months, and 11 patients in the 
control group - 9 men and 2 women, with duration of disease 7.3 ± 1.5 months). To evaluate the changes in the 
gait were followed cadence of 6 m and 10 m and the speed of movement which are the most informative kinetic 
parameters. Patients in the experimental group were treated with a specialised 10-day KT, which later continued 
to be performed as an adapted exercise program at home for one month.
 
RESULTS: After applying specialised kinesitherapeutic methodology (SKTM), the highest trend towards 
improvement in the kinetic parameters of gait was established after the 1st month with a level of significance 
during treatment p < 0.001. 
CONCLUSION: The enclosed SKTM in the experimental group continued later as an adapted exercise program 
at home, significantly improving the kinetic parameters of gait in patients with SUSChP, compared with the usual 
kinesi-therapeutic methodology applied in the control group. 
 
 
 
 
 
Introduction 
 
Normal human gait is a natural movement 
defined as bipedal and biphasic forward centre of 
gravity with minimal energy expenditure while walking. 
This is the result of dynamic interactions between 
central program and feedback mechanisms [1].  
Difficulties in walking in stroke patients are 
due to many factors, such as reduced muscle strength 
imbalance in weight distribution, impaired 
proprioception, increased tendon reflexes, spasticity 
and impairment in motor control [2].
 
Typical gait disturbances that occur after 
stroke for impairments in the middle cerebral artery 
with consecutive one-sided weakness and spasticity 
are: reduced flexion of the knee in swing phase and 
phase of support, hyperextension of the knee 
(dynamic recurvate) phase of support and excessive 
plantar flexion of the ankle (equines) in swing phase 
and/or the phase of support. Each of these 
impairments has a potential negative effect and 
increases the need for energy for walking. For 
reduced flexion of the knee in the swing phase, 
sometimes are necessary compensatory mechanisms 
such circumduction hip, lifting hip and contralateral 
footing with an excessive elevation of the pelvis. 
Inadequate knee flexion in supporting phase led to a 
relatively higher position of the centre of gravity of the 
body. Similarly hyperextension of the knee can 
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change the center of gravity in the support phase and 
cause damage to the knee because overstretching of 
ligaments and capsular structures: the vertical 
component of the reaction force of the support 
(external structure) and muscle strength (internal 
structure) appear together to cause a moment of 
extension in the knee. Equinus foot in the swing 
phase may be due to the weakness of the dorsal 
flexor ankle, plantar flexor spasticity and plantar 
flexion contracture of the ankle. In the supporting 
phase, the last reasons can cause hyperextension of 
the knee by preventing the gradual dorsal flexion of 
the ankle, which usually begins during the reaction of 
the load and remains in final supporting phase [3-5].  
After stroke more time is spent in the 
supporting phase of the unaffected side, and this is 
the main reason for the reduced speed of gait. The 
continuous supporting phase of the intact leg side is 
due to the slow movement of the affected foot. 
Specifically, in patients with stroke, the swing phase of 
the affected limb lasts longer due to delayed initiation 
and reduced speed of flexion of the hip [6]. The 
difficulties of the affected limb in swing phase are 
associated with reduced flexion knee limited by the 
spasticity of the m. quadriceps femoris [4, 7]. 
The majority of the recovery of the gait 
following a stroke occurs in a stereotyped manner. It 
is associated with the stored generators central 
programs in the spinal cord that operate under the 
influence of template supraspinal signals by seeking 
maximum to preserve the basic structure of gait and 
its programming. This is possible due to uncorrupted 
connections to the brainstem and unaffected 
hemisphere [6].
 
The central mechanisms for functional 
recovery are not fully understood. In the early period 
of brain damage processes of restitution, adaptable 
reorganisation and compensatory strategies are 
undergoing. In the late period (after 6 months) occurs 
organising new neural network which overlaps 
damaged premorbid network [8]. Recovery depends 
on the severity, the extent of damage to the brain 
tissue and the applied kinesitherapy [5]. 
The gait of patients with chronic post-stroke 
hemiparesis is realised by using compensatory 
strategies that are alternatively replacement behaviour 
of the motor deficit. They appear as the adaptive and 
optimal realisation of the final motor response and can 
be evaluated and documented by analysing the 
human step [9-17]. 
The step of the patients with unilateral stroke 
reflects bilateral changes in motor control in which the 
participation of nonparetic side is greater and 
correlates with the extent of brain reorganisation [11, 
12, 14, 17]. 
Despite the continuous development of 
neurorehabilitation, many patients with stroke have 
permanent disabilities in walking that affect their 
quality of life and their ability to participate in the 
activities of daily life [18, 19]. In patients with chronic 
post-stroke hemiparesis short 3 weeks 
neurorehabilitation improve temporal, spatial and 
stepping indicators gait - increases the normal speed 
of movement, reduces the duration of the phases of 
gait and increases its length predominantly nonparetic 
side, without affecting the asymmetry of the kinetic 
and stepper indicators and their coefficient of variation 
[6]. 
The aim of this study was to trace the early 
(10th day) and late (1st month) effect of the 
specialised kinesitherapeutic methodology (SKTM) on 
the kinetic parameters of gait. It is based on 
contemporary principles of neurorehabilitation 
adapted for home use with the individual needs of 
patients with supratentorial unilateral stroke in the 
chronic period (SUSChP). 
 
 
Material and Methods 
 
Methodology of the research 
The research includes a study of 67 patients 
with SUSChP (56 patients included in the 
experimental group - 32 men and 24 women, with 
duration of disease 7.8 ± 2.0 months, and 11 patients 
in the control group - 9 men and 2 women, with 
duration of disease 7.3 ± 1.5 months). 
The clinical characteristics of the patients are 
given in Table 1. To determine the severity of the 
paresis, a modified scale Chedoke-McMaster was 
used, according to which patients with 4th and 5th 
stages are with moderate disease, while patients of 
6th and 7th the stage have mild impairment [20, 21]. 
On this basis, the patients are divided into two 
subgroups (moderate and mild impairment). 
Table 1: Clinical characteristics of contingent baseline 
Parameters Patients Moderate degree Mild degree 
Experimental group N = 56 N = 33 N = 23 
Age 63.2 ± 8.8 63.9 ± 7.1 62.3 ± 10.9 
Sex (men/women ) 32/24 22/11 10/13 
Limitation periods   (months) 7.8 ± 2.0 8.3 ± 2.2 7.2 ± 1.5 
Localization  (left/right) 26/30 16/17 10/13 
 
Control group 
 
N = 11 
 
N = 5 
 
N = 6 
Age 63.3 ± 6.0 63.6 ± 5.3 63.1 ± 7.1 
Sex (men/women) 9/2 5/0 4/2 
Limitation periods  (months) 7.3 ± 1.5 7.6 ± 1.8 7.0 ± 1.2 
Localization (left/right) 5/6 2/3 3/3 
Mean ± SD - mean and standard deviation; EG - the experimental group; KG - control 
group. The significance of the intra-group changes is defined by the binominal test. 
Intergroup significance of sex and localisation is determined by U-criteria of Mann-Whitney 
for independent samples, while for age and limitation period, a Student t-test for 
independent samples is attached.
 
 
The existence of homogeneity in the study did 
not include patients with acute stroke and brain 
haemorrhage spent, as well as with the case of 
bilateral or severe paresis. After the selection of 
patients additionally were excluded from the study 
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patients who have refused to participate in the study 
for various reasons (greater distance they need to 
travel, business and family commitments) and those 
who were prescribed a change of drug therapy during 
the applied treatment. All patients were able to move 
independently or with assistance without serious 
problems in communication and previously prescribed 
medication therapy by neurologists, including 
antiplatelet and antihypertensive drugs. 
Changes in gait before and after the treatment 
were recorded; the cadence of gait and maximum 
travel speed was estimated. To determine the 
cadence, the number of steps to cover 6 m and 10 m 
was measured. The patient was asked to walk with 
the preferred speed [22]. The speed of the gait is 
defined in m /min, dividing the distance undergone (m) 
by the time it took the individual to walk that distance.  
All parameters were evaluated three times - at 
the beginning of the study, the 10th day and 1st 
month after the start of kinesitherapy. 
 
Methods of kinesitherapy 
The experimental group comprised 56 
patients (32 men and 24 women) with duration of 
disease 7.8 ± 2.0 months who received a specialised 
kinesitherapeutic methodology (SKTM) for 10 days 
and then continues to run at home as adjusted 
program of exercises over a period of 3 weeks [23].
 
The control group (CG) consisted of 11 
patients (9 men and 2 women) with duration of the 
disease 7.3 ± 1.5 months treated in a routine manner 
by a conventional 10-day kinesitherapeutic 
methodology. They were held only trace control 
without meeting kinesitherapeutic program after 10 
days of treatment. 
The attached two kinesitherapeutical methods 
are different in treatment duration, structure and 
incorporated applied kinesitherapy (postural 
movements, walking, active movements of the upper 
limbs and transfers). In SKTM, principles of modern 
neurorehabilitation and motor learning as opposed to 
usual kinesitherapy. 
It is based on the fundamental principles of 
modern neurorehabilitation, namely: to be 
individualized, intensive and specifically - tailored and 
focused on the individual needs of the patient; be 
realized with the active participation of the patient and 
his family, with prolonged use so as to ensure that 
care tailored to the needs of the patient throughout his 
life to achieve recovery and relief of late complications 
of the disease [8]. 
Specialised kinesitherapeutic methodology 
conforms to the principles of motor learning. They are 
specificity of the task, active participation of the 
patient repetition adaptation of complexity, feedback 
variability "contextual interference" [24]. 
Statistics 
Used is a suite of statistical programs for 
quantitative processing of data received. Attached is 
variation (Student-Fisher t-test), alternative and 
correlation analysis for objectifying the changes of the 
applied treatment. 
When comparing the non-parametric 
parameters in the course of treatment, Wilcoxon test 
was used, to determine the significance of differences 
between groups was given U-criterion of Mann-
Whitney. 
Paired Samples Test was applied to compare 
the parametric performance. An alternative analysis is 
used to determine the significance in the percentage 
of patients. 
The correlation analysis Spearman is used to 
search for a link between changes in various 
indicators. 
 
 
Results 
 
Comparative assessment of monitored 
indicators objectifying changes in gait in patients with 
experimental and control groups is presented in Table 
2. 
Table 2:  Evaluation of cadence and speed of gait in the 
monitored patients during treatment 
Parameters Groups At the beginning  
EG (n = 56) 
CG (n = 11) 
_ 
Х ± SD 
10th day  
EG (n = 56) 
CG (n = 11) 
_ 
Х ± SD 
1st month 
EG (n = 56) 
CG (n = 11) 
_ 
Х ± SD 
 
6 m 
(number of steps) 
 
EG 
CG 
P 
 
9.6 ± 3.7 
7.4 ± 1.0 
0.057 
 
8.1 ± 3.0 *** 
6.6 ± 0.7 ** 
0.122 
 
7.3 ± 2.3 *** 
7.0 ± 0.6 * 
0.694 
 
10 m 
(number of steps) 
 
EG 
CG 
P 
 
 
16.4 ± 6.3 
13.1 ± 1.7 
0.097 
 
14.0 ± 5.3 *** 
11.7 ± 1.9 ** 
0.149 
 
12.2 ± 4.1 *** 
12.5 ± 1.6 * 
0.856 
Speed of gait 
(m/min) 
EG 
CG 
P 
31.3 ± 16.6 
36.1 ± 14.3 
0.371 
 
39.4 ± 16.6 *** 
42.1 ± 11.8 ** 
0.605 
46.1 ± 16.2 *** 
41.5 ± 11.6 ** 
0.380 
_ 
Х ± SD – mean and standard deviation, *** p < 0.001, ** p < 0.01, * p <0.05 - significant 
change compared to baseline in the course of treatment assessed by Wilcoxon Test; P - 
the significance of the change between the two groups as measured by U-criteria of Mann-
Whitney Test. The reduced number of steps and the increased speeds mean an 
improvement in the kinematic parameters of gait. 
 
 
The difference between net and baseline at 
the studied patients from both groups is presented in 
Figure 1. 
After the applied kinesitherapy, a significant 
improvement in gait is seen in all patients. Compared 
to baseline a significant reduction in the number of 
steps is present when walking 6 m and 10 m, and an 
increase of the speed of gait throughout the follow-up 
period. 
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Figure 1: Changes in gait cadence of 6 m and 10 m, represented as 
the difference between the results obtained and output values of the 
two groups studied (top). Changes in the speed of movement 
represented as the difference between the results obtained and the 
baseline in both treatment groups (bottom) 
 
In the monitored patient's experimental group 
a significant reduction is found in the number of steps 
when walking 6 m and 10 m (from 9.6 to 8.1 - 6 m, 
and from 16.4 to 14.0 - 10 m walking) on the 10th day. 
In the first month after the start of treatment in 
cadence changes are expressed in the fact that the 
number of steps decreases to 7.3 at 6 m and 12.2 m 
at 10 m walking, with a significance level of p < 0.001. 
Data speed of gait in the experimental group 
is similar. The initial velocity of the gait is 31.3 m/min 
that after day 10 tends to increase up to 39.4 m/min 
and is a most pronounced increase in the 1st month 
(46.1 m/min), with a level of significance p < 0.001. 
The output data of the control group did not 
differ significantly from EG. After attached 
kinesitherapeutic common methodology with 10-day 
duration, a trend is established of significantly 
reducing the number of steps from 7.4 to 6.6 feet of 6 
m, and from 13.1 to 11.7 feet of 10 m. The first month 
as a result of the lack of performance of the targeted 
exercise, as compared to day 10 the number of steps 
increases is established whereby at 6 m is 7 m and 10 
m is 12.5 steps, i.e. there is a tendency to return to 
baseline.
 
The speed of gait in the control group is an 
initial value of 36.1 m/min, which after day 10 is 
tending to increase up to 42.1 m/min and the 1st 
month insignificant decreased to 41.5 m/min. Although 
in absolute terms the change is more pronounced for 
the experimental group, there was no significant 
difference from the application of the two 
methodologies kinesitherapeutic at the end of the 
detected period. 
Changes in the EG in the kinematic 
parameters of gait, depending on the severity of the 
impairments and the importance between subgroups 
studied are presented in Table 3. 
Table 3:   Changes in cadence and speed of gait according to 
the severity of involvement in the experimental group during 
treatment 
Parameters Subgroups  At the beginning   
Moderate  
(n = 33) 
Mild (n = 23) 
_ 
Х±SD 
10
th
 day  
Moderate  
(n = 33) 
Mild (n = 23) 
_ 
Х±SD 
1
st
 month  
Moderate  
(n = 33) 
Mild (n = 23) 
_ 
Х±SD 
 
6 m 
(number of steps) 
 
10 m 
(number of steps) 
 
Speed of gait 
(m/min) 
 
 
Moderate  
Mild 
P  
 
Moderate  
Mild 
P 
 
Moderate  
Mild 
P 
 
11.2 ± 3.8 
7.2 ± 2.0 
0.000 
 
19.1 ± 6.3 
12.4 ± 3.6 
0.000 
 
22.5 ± 14.4 
44.0 ± 9.9 
0.000 
 
9.4 ± 3.2 *** 
6.2 ± 1.2***  
0.000 
 
16.5 ± 5.4 *** 
10.7 ± 2.5 *** 
0.000 
 
30.0 ± 15.1 *** 
52.9 ± 5.9***  
0.000 
 
8.2 ± 2.5 *** 
5.9 ± 1.1 ***  
0.000 
 
14.0 ± 4.4 *** 
9.7 ± 1.9 ***  
0.000 
 
36.2 ± 13.8*** 
60.2 ± 5.5*** 
0.000 
_ 
Х±SD – mean and standard deviation, *** p < 0.001, ** p < 0.01, * p < 0.05 - significant 
change compared to baseline in the course of treatment assessed by Wilcoxon Test; P 
<0.001 - the significance of the change between the two subgroups as measured by U-
criteria of Mann-Whitney Test. The reduced number of steps and speed increase mean an 
improvement in the kinematic parameters of gait. 
 
It was found that in the EG at the beginning of 
the treatment performed between two subgroups with 
moderate and mild effect there is a significant 
difference (P < 0.001). Compared with the supplied 
10-day treatment, improvement in all patients is 
significant and most pronounced in the 1st month of 
the study. In absolute terms, the positive effect of the 
applied SKTM is more pronounced in patients with 
mild severity of impairment, although the significance 
of the changes between the two groups was 
maintained until the end of treatment. 
Table 4:  Changes in cadence and speed of gait according to 
the severity of involvement in the control group during 
treatment 
Parameters Subgroups At the beginning  
Moderate  
(n = 5) 
Mild (n = 6) 
_ 
Х ± SD 
10
th
 day  
Moderate  
(n = 5) 
Mild (n = 6) 
_ 
Х ± SD 
1
st
 month 
Moderate  
(n = 5) 
Mild (n = 6) 
_ 
Х ± SD 
 
6 m 
(number of steps) 
 
10 m 
(number of steps) 
 
Speed of gait 
(m/min) 
 
 
Moderate  
Mild 
P  
 
Moderate  
Mild 
P 
 
Moderate  
Mild 
P 
 
7.9 ± 0.6 
7.0 ± 1.1 
0.126 
 
14.1 ± 1.2 
12.4 ± 2.0 
0.145 
 
24.4 ± 11.3 
46.0 ± 7.1 
0.004 
 
7.0 ± 0.6  
6.4 ± 0.7 ** 
0.247 
 
12.6 ± 1.3 ** 
10.9 ± 2.2 * 
0.171 
 
31.8 ± 9.2 ** 
50.8 ± 3.5   
0.001 
 
7.3 ± 0.2  
6.7 ± 0.7 * 
0.177 
 
13.3 ± 0.9 * 
11.8 ± 1.8  
0.148 
 
31.4 ± 9.1 ** 
50.0 ± 3.6 
0.001 
_ 
Х±SD – mean and standard deviation, ** p < 0.01, * p < 0.05 - significant change compared 
to baseline in the course of treatment assessed by Wilcoxon Test; P <0.01 - the 
significance of the change between the two subgroups as measured by U-criteria of Mann-
Whitney Test. The reduced number of steps and speed increase mean an improvement in 
the kinematic parameters of gait. 
 
In control patients, significant differences 
were established between patients with mild and 
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moderate severity during the treatment only for the 
speed of gait (Table 4). These positive changes are 
associated with a significant improvement in patients 
with moderate severity of impairment throughout the 
follow-up period.
 
There were no significant correlations 
between changes in gait and the age, sex of the 
patient, duration of the disease and the localisation of 
the pathological process.
 
 
 
Discussion 
 
The survey results show a positive effect of 
applied kinesitherapeutical methods on gait in both 
groups, although in absolute terms it is for specialised 
methodology.
 
A distinct positive change in absolute values 
in the experimental group on day 10 and primarily the 
1st month on gait, probably are due to the included 
movements of lower limbs, control of the trunk and 
pelvis and swimming which normalize movements of 
the lower limb, the healthy and the affected side of the 
body as well as the consistency of motor response. 
They stimulate a response in the quadriceps femoris 
muscle and facilitate walking. Of essential importance 
are the walking and dosed swimming involved in the 
methodology, leading to normalisation of the control 
body and upper extremities, improved dynamic control 
and ease of movement. Similar are claims of other 
authors who establish a positive influence on the 
ability and walking speed [25-27]. 
The positive effect on the recovery of gait in 
both groups linked to the fact that walking can be 
exercised continuously in daily life in patients for 
whom this activity is possible.
 
Improvement in gait in patients with unilateral, 
chronic stroke is established by a research of E. 
Titianova (2007) after a 3-week specialized program 
for neurorehabilitation, including over 20 min walking 
with electromechanical simulator for 25 min 
kinesitherapy (immediately after the simulator) 30 min 
kinesitherapy (in the afternoon aimed at training gait) 
and 30 min, group kinesitherapy to train the balance, 
swimming, sitting and relaxation. The improvement is 
significant regarding the kinetics of gait but does not 
change the central programming stepper footprint 
regarding chronic neurological deficit. These data are 
associated with the results obtained in this study, 
which also records improvement in walking speed 
related to better daily opportunities [6].
 
A possible explanation of one-month positive 
effect on gait in patients studied is probably due to 
those targeted functional activities included in SKTM 
which seek active participation by the patient to gain 
experience and to seize the opportunities of the 
processes of neuroplasticity recovery. The patient 
must learn strategies for solving specific mobility 
problems, optimal orientation of the body, a good 
starting position, the ability to perform a sequence of 
movements to enable the use of skills that are 
adaptable in everyday life [23, 28]. 
A distinct improvement in gait in the 
experimental group is associated with the 1-month 
application of the presented methodology. In patients 
with chronic post-stroke hemiparesis application of 3-
week specialised neurorehabilitation improves spatial 
and temporal parameters of gait causing a significant 
increase in normal speed, the length of step and stride 
as a result of a significant reduction in their length [6, 
14]. For a successful kinesitherapy is an essential 
optimal balance between duration of treatment and 
clinical recovery of the patient [8, 29, 30]. 
In conclusion, the applied SKTM significantly 
improves gait and increases walking speed as the 
observed beneficial effects accumulate throughout the 
follow-up period and with a maximum expression in 
the 1st month of treatment. Unlike the patients in the 
control group, SKTM showed progressive 
improvement throughout the follow-up period. 
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